|
REVXF
|
Revenio Group Oyj
|
US
|
US
|
|
IRD
|
Opus Genetics, Inc.
|
US
|
US
|
|
0OT
|
Ocular Therapeutix Inc
|
DE
|
F
|
|
2H51
|
Ocugen Inc
|
DE
|
F
|
|
328
|
MEIRAGTX HLDGSDL-0000388
|
DE
|
F
|
|
6DW
|
D. Western Therapeutics Institute Inc
|
DE
|
F
|
|
6GJ
|
Glaukos Corporation
|
DE
|
F
|
|
D9Z
|
Clínica Baviera S.A
|
DE
|
F
|
|
K27
|
KODIAK SCIENCES DL-0001
|
DE
|
F
|
|
PV3B
|
EYEPOINT PHARMAC. DL-01
|
DE
|
F
|
|
R0V
|
REVENIO GROUP CORP. EO 15
|
DE
|
F
|
|
R3X1
|
OCUPHIRE PHARMA DL-0001
|
DE
|
F
|
|
RGO
|
Regeneron Pharmaceuticals Inc
|
DE
|
F
|
|
FYB
|
Formycon AG
|
DE
|
XETRA
|
|
LOTUSEYE
|
Lotus Eye Hospital and Institute Limited
|
IN
|
NSE
|
|
EYE
|
Nova Eye Medical Ltd
|
AU
|
AU
|
|
PYC
|
PYC Therapeutics Ltd
|
AU
|
AU
|